| 1. |
- Thomas, HS, et al.
(författare)
-
- 2019
-
swepub:Mat__t
|
|
| 2. |
|
|
| 3. |
- Joffrin, E., et al.
(författare)
-
Overview of the JET preparation for deuterium-tritium operation with the ITER like-wall
- 2019
-
Ingår i: Nuclear Fusion. - : IOP Publishing. - 1741-4326 .- 0029-5515. ; 59:11
-
Forskningsöversikt (refereegranskat)abstract
- For the past several years, the JET scientific programme (Pamela et al 2007 Fusion Eng. Des. 82 590) has been engaged in a multi-campaign effort, including experiments in D, H and T, leading up to 2020 and the first experiments with 50%/50% D-T mixtures since 1997 and the first ever D-T plasmas with the ITER mix of plasma-facing component materials. For this purpose, a concerted physics and technology programme was launched with a view to prepare the D-T campaign (DTE2). This paper addresses the key elements developed by the JET programme directly contributing to the D-T preparation. This intense preparation includes the review of the physics basis for the D-T operational scenarios, including the fusion power predictions through first principle and integrated modelling, and the impact of isotopes in the operation and physics of D-T plasmas (thermal and particle transport, high confinement mode (H-mode) access, Be and W erosion, fuel recovery, etc). This effort also requires improving several aspects of plasma operation for DTE2, such as real time control schemes, heat load control, disruption avoidance and a mitigation system (including the installation of a new shattered pellet injector), novel ion cyclotron resonance heating schemes (such as the three-ions scheme), new diagnostics (neutron camera and spectrometer, active Alfven eigenmode antennas, neutral gauges, radiation hard imaging systems...) and the calibration of the JET neutron diagnostics at 14 MeV for accurate fusion power measurement. The active preparation of JET for the 2020 D-T campaign provides an incomparable source of information and a basis for the future D-T operation of ITER, and it is also foreseen that a large number of key physics issues will be addressed in support of burning plasmas.
|
|
| 4. |
- van der Lee, S. J., et al.
(författare)
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
- 2019
-
Ingår i: Acta Neuropathologica. - : Springer Science and Business Media LLC. - 0001-6322 .- 1432-0533. ; 138:2, s. 237-250
-
Tidskriftsartikel (refereegranskat)abstract
- The genetic variant rs72824905-G (minor allele) in the PLCG2 gene was previously associated with a reduced Alzheimer's disease risk (AD). The role of PLCG2 in immune system signaling suggests it may also protect against other neurodegenerative diseases and possibly associates with longevity. We studied the effect of the rs72824905-G on seven neurodegenerative diseases and longevity, using 53,627 patients, 3,516 long-lived individuals and 149,290 study-matched controls. We replicated the association of rs72824905-G with reduced AD risk and we found an association with reduced risk of dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). We did not find evidence for an effect on Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) risks, despite adequate sample sizes. Conversely, the rs72824905-G allele was associated with increased likelihood of longevity. By-proxy analyses in the UK Biobank supported the associations with both dementia and longevity. Concluding, rs72824905-G has a protective effect against multiple neurodegenerative diseases indicating shared aspects of disease etiology. Our findings merit studying the PLC gamma 2 pathway as drug-target.
|
|
| 5. |
- Batistoni, P., et al.
(författare)
-
14 MeV calibration of JET neutron detectors-phase 2 : in-vessel calibration
- 2018
-
Ingår i: Nuclear Fusion. - : IOP PUBLISHING LTD. - 0029-5515 .- 1741-4326. ; 58:10
-
Tidskriftsartikel (refereegranskat)abstract
- A new DT campaign (DTE2) is planned at JET in 2020 to minimize the risks of ITER operations. In view of DT operations, a calibration of the JET neutron monitors at 14 MeV neutron energy has been performed using a well calibrated 14 MeV neutron generator (NG) deployed, together with its power supply and control unit, inside the vacuum vessel by the JET remote handling system. The NG was equipped with two calibrated diamond detectors, which continuously monitored its neutron emission rate during the calibration, and activation foils which provided the time integrated yield. Cables embedded in the remote handling boom were used to power the neutron generator, the active detectors and pre-amplifier, and to transport the detectors' signal. The monitoring activation foils were retrieved at the end of each day for decay gamma-ray counting, and replaced by fresh ones. About 76 hours of irradiation, in 9 days, were needed with the neutron generator in 73 different poloidal and toroidal positions in order to calibrate the two neutron yield measuring systems available at JET, the U-235 fission chambers (KN1) and the inner activation system (KN2). The NG neutron emission rates provided by the monitoring detectors were in agreement within 3%. Neutronics calculations have been performed using MCNP code and a detailed model of JET to derive the response of the JET neutron detectors to DT plasma neutrons starting from the response to the NG neutrons, and taking into account the anisotropy of the neutron generator and all the calibration circumstances. These calculations have made use of a very detailed and validated geometrical description of the neutron generator and of the modified. MNCP neutron source subroutine producing neutron energy-angle distribution for the neutrons emitted by the NG. The KN1 calibration factor for a DT plasma has been determined with +/- 4.2%' experimental uncertainty. Corrections due to NG and remote handling effects and the plasma volume effect have been calculated by simulation modelling. The related additional uncertainties are difficult to estimate, however the results of the previous calibration in 2013 have demonstrated that such uncertainties due to modelling are globally <= +/- 3%. It has been found that the difference between KN1 response to DD neutrons and that to DT neutrons is within the uncertainties in the derived responses. KN2 has been calibrated using the Nb-93(n,2n)Nb-92m and Al-27(n,a)Na-24 activation reactions (energy thresholds 10 MeV and 5 MeV respectively). The total uncertainty on the calibration factors is +/- 6% for Nb-93(n,2n)Nb-92m and +/- 8% Al-27(n,a)Na-24 (1 sigma). The calibration factors of the two independent systems KN1 and KN2 will be validated during DT operations. The experience gained and the lessons learnt are presented and discussed in particular with regard to the 14 MeV neutron calibrations in ITER.
|
|
| 6. |
|
|
| 7. |
- Parsonage, Ben, et al.
(författare)
-
Control of antimicrobial resistance requires an ethical approach
- 2017
-
Ingår i: Frontiers in Microbiology. - : Frontiers Media S.A.. - 1664-302X. ; 8:NOV
-
Forskningsöversikt (refereegranskat)abstract
- Ethical behavior encompasses actions that benefit both self and society. This means that tackling antimicrobial resistance (AMR) becomes an ethical obligation, because the prospect of declining anti-infectives affects everyone. Without preventive action, loss of drugs that have saved lives over the past century, will condemn ourselves, people we know, and people we don't know, to unacceptable risk of untreatable infection. Policies aimed at extending antimicrobial life should be considered within an ethical framework, in order to balance the choice, range, and quality of drugs against stewardship activities. Conserving availability and effectiveness for future use should not compromise today's patients. Practices such as antimicrobial prophylaxis for healthy people 'at risk' should receive full debate. There are additional ethical considerations for AMR involving veterinary care, agriculture, and relevant bio-industries. Restrictions for farmers potentially threaten the quality and quantity of food production with economic consequences. Antibiotics for companion animals do not necessarily spare those used for humans. While low-income countries cannot afford much-needed drugs, pharmaceutical companies are reluctant to develop novel agents for short-term return only. Public demand encourages over-the-counter, internet, black market, and counterfeit drugs, all of which compromise international control. Prescribers themselves require educational support to balance therapeutic choice against collateral damage to both body and environment. Predicted mortality due to AMR provides justification for international co-operation, commitment and investment to support surveillance and stewardship along with development of novel antimicrobial drugs. Ethical arguments for, and against, control of antimicrobial resistance strategies are presented and discussed in this review.
|
|
